日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks

罗氟司特泡沫剂0.3%治疗脂溢性皮炎患者的长期安全性和有效性：一项长达52周的II期开放标签试验

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00984-2
Alexis, Andrew F; Bukhalo, Michael; Cook-Bolden, Fran E; Del Rosso, James Q; Draelos, Zoe D; DuBois, Janet C; Ferris, Laura K; Forman, Seth B; Kempers, Steven E; Kircik, Leon H; Lain, Edward; Moore, Angela Y; Pariser, David M; Raoof, Joseph; Zirwas, Matthew J; Seal, Melissa S; Kato, Saori; Chu, David H; Krupa, David; Snyder, Scott; Burnett, Patrick; Berk, David R
发表日期：2026
文献求助 收藏

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis

鲁索替尼乳膏治疗2-11岁中重度特应性皮炎患儿的最大剂量试验

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-024-00909-5
Stein Gold, Linda; Bissonnette, Robert; Forman, Seth; Zaenglein, Andrea; Kuo, YuTzu; Angel, Brett; Chen, Xuejun; Kallender, Howard; Paller, Amy S
发表日期：2025
文献求助 收藏

Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo

鲁索替尼乳膏治疗白癜风患者3期临床试验的长期综合安全性总结

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01555-3
Rosmarin, David; Pandya, Amit G; Passeron, Thierry; Forman, Seth B; Zdybski, Jacek; Amster, Mark; Feser, Christina; Papp, Kim A; Nuara, Anthony; Kornacki, Deanna; Wei, Shaoceng; Ren, Haobo; Harris, John E; Ezzedine, Khaled
发表日期：2025
文献求助 收藏

Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II

比美珠单抗对中重度化脓性汗腺炎患者患者报告结局的影响：BE HEARD I&II 研究的 48 周汇总结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01465-4
Shi, Vivian Y; Ingram, John R; Lev-Tov, Hadar; Schneider-Burrus, Sylke; Forman, Seth; Porter, Martina L; Hayama, Koremasa; Thorlacius, Linnea; Lambert, Jérémy; Vaux, Tom; Lukowski, Bartosz; Rolleri, Robert L; Szepietowski, Jacek C
发表日期：2025
文献求助 收藏

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical Trial

PF-07038124治疗特应性皮炎和斑块状银屑病患者的疗效和安全性：一项随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2023.4990
Eichenfield, Lawrence F; Tarabar, Sanela; Forman, Seth; García-Bello, Alfonso; Feng, Gang; Fetterly, Gerald; Mahling, Ping; Peeva, Elena; Vincent, Michael S; Chandra, Deepa E
银屑病
发表日期：2024
文献求助 收藏

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial

Zasocitinib (TAK-279) 抑制酪氨酸激酶 2 治疗银屑病：一项随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2024.2701
Armstrong, April W; Gooderham, Melinda; Lynde, Charles; Maari, Catherine; Forman, Seth; Green, Lawrence; Laquer, Vivian; Zhang, Xinyan; Franchimont, Nathalie; Gangolli, Esha A; Blau, Jessamyn; Zhao, Yiwei; Zhang, Wenwen; Srivastava, Bhaskar; Heap, Graham; Papp, Kim
信号转导
银屑病
发表日期：2024
文献求助 收藏

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials

罗氟司特乳膏，0.15%，用于治疗成人和儿童特应性皮炎：INTEGUMENT-1 和 INTEGUMENT-2 随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2024.3121
Simpson, Eric L; Eichenfield, Lawrence F; Alonso-Llamazares, Javier; Draelos, Zoe D; Ferris, Laura K; Forman, Seth B; Gooderham, Melinda; Gonzalez, Mercedes E; Hebert, Adelaide A; Kircik, Leon H; Lomaga, Mark; Moore, Angela; Papp, Kim A; Prajapati, Vimal H; Hanna, Diane; Snyder, Scott; Krupa, David; Burnett, Patrick; Almaraz, Erin; Higham, Robert C; Chu, David H; Berk, David R
发表日期：2024
文献求助 收藏

ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.

局部用 Jak1/3 抑制剂 ATI-1777 可能在不进行全身用药的情况下使特应性皮炎受益：临床前开发和 2a 期随机对照研究 ATI-1777-AD-201 的结果

期刊:JID Innovations
影响因子:
doi:10.1016/j.xjidi.2023.100251
Changelian Paul, Xu Canxin, Mnich Steve, Hope Heidi, Kostecki Kourtney, Hirsch Jeff, Loh Chin-Yi, Anderson David, Blinn James, Hockerman Susan, Dick Evan, Smith Walter, Monahan Joseph, Raoof Tooraj, Forman Seth, Burt David, Barnes Brad, Gordon David, Walker Neal, Sudzina John, Tucker Stephen, Jacobsen Jon
炎症/感染
炎症
发表日期：2024
文献求助 收藏

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

罗氟司特泡沫剂（0.3%）治疗脂溢性皮炎患者的疗效：一项双盲、赋形剂对照的 2a 期随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2023.0846
Zirwas, Matthew J; Draelos, Zoe D; DuBois, Janet; Kircik, Leon H; Moore, Angela Y; Stein Gold, Linda; Alonso-Llamazares, Javier; Bukhalo, Michael; Bruce, Suzanne; Eads, Kimmie; Green, Lawrence J; Guenthner, Scott T; Ferris, Laura K; Forman, Seth B; Kempers, Steven E; Lain, Edward; Lynde, Charles W; Pariser, David M; Toth, Darryl P; Yamauchi, Paul S; Higham, Robert C; Krupa, David; Burnett, Patrick; Berk, David R
发表日期：2023
文献求助 收藏

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials

在巴瑞替尼 III 期临床试验中，瘙痒和皮肤严重程度改善对特应性皮炎患者皮肤病生活质量指数的贡献

期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.21015
Yosipovitch, Gil; Papp, Kim; Forman, Seth; Han, George; Waibel, Jill; Rueda, Maria J; Sun, Luna; Chen, Yun-Fei; Goldblum, Orin; Pierce, Evangeline; Silverberg, Jonathan I
发表日期：2022
文献求助 收藏